Acemetacin in the treatment of rheumatic diseases: an open, multi-centre trial.

Abstract:

:An open, multi-centre trial was carried out to assess the efficacy and tolerance of acemetacin in the treatment of patients suffering from various rheumatic diseases. The patients were treated by general practitioners for a maximum period of 6 weeks with a daily dose of 60 mg acemetacin 3-times daily. Assessments were made before, during and after treatment of pain parameters, joint function and swelling, and records kept of any adverse events reported. At the end of treatment, the physician made an overall assessment of response. Data from 760 patients were analyzed and showed 'very good' or 'good' improvement in 55% and 28.5% of patients, respectively. A relatively low percentage (16.3%) reported adverse events, which may or may not have been drug related, and there were few reports (10.7%) of gastric complaints. Twenty-seven (3.6%) patients withdrew from the study for reasons not specified.

journal_name

Curr Med Res Opin

authors

Rechziegler H,Zündorf P

doi

10.1185/03007998509109654

subject

Has Abstract

pub_date

1985-01-01 00:00:00

pages

701-7

issue

10

eissn

0300-7995

issn

1473-4877

journal_volume

9

pub_type

临床试验,杂志文章
  • The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication.

    abstract:OBJECTIVES:Cardiovascular disease (CVD) is the leading cause of mortality worldwide. A high level of low-density lipoprotein cholesterol (LDL-C) is a major CVD risk factor. Guidelines recommend effective cholesterol management and set LDL-C goals, yet deficiencies exist in physician implementation of these recommendati...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079908x280491

    authors: Hobbs FD,Erhardt LR,Rycroft C,Heart study investigators.

    更新日期:2008-05-01 00:00:00

  • Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma.

    abstract:OBJECTIVE:To provide a commentary on recent studies with the new IOP-lowering fixed-combination product brinzolamide 1%/timolol 0.5%. METHODS:Medline was searched for brinzolamide/timolol fixed-combination clinical literature (up to May 18, 2010) and the current comprehensive brinzolamide/timolol literature was review...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2010.517718

    authors: Januleviciene I

    更新日期:2010-11-01 00:00:00

  • Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone.

    abstract:OBJECTIVE:Thiazide diuretics such as hydrochlorothiazide (HCT) are a widely used first-line treatment for hypertension, but most patients will not achieve blood pressure (BP) control with HCT alone and so will require combination therapy. In this study the efficacy, safety and tolerability of a single-pill combination ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1185/03007990902804158

    authors: Blumenstein M,Romaszko J,Calderón A,Andersen K,Ibram G,Liu Z,Zhang J

    更新日期:2009-04-01 00:00:00

  • Paclitaxel-based versus docetaxel-based regimens in metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.

    abstract:OBJECTIVES:Docetaxel and paclitaxel show significant clinical activity in metastatic breast cancer (MBC) and have been approved for MBC by the U.S. Food and Drug Administration, but it is still unclear whether a paclitaxel-based regimen improves outcomes over a docetaxel-based regimen in patients with MBC. We therefore...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,meta分析,评审

    doi:10.1185/03007995.2012.756393

    authors: Qi WX,Shen Z,Lin F,Sun YJ,Min DL,Tang LN,He AN,Yao Y

    更新日期:2013-02-01 00:00:00

  • Clinical utility of a biopsy-based cell cycle gene expression assay in localized prostate cancer.

    abstract:OBJECTIVE:The CCP signature test (Prolaris) quantifies a patient's risk of disease progression and prostate cancer specific mortality using a gene-expression-based cell cycle progression (CCP) score. This study evaluated the potential clinical utility of the CCP test in a US-based clinical setting. METHODS:Urologists ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.873398

    authors: Shore N,Concepcion R,Saltzstein D,Lucia MS,van Breda A,Welbourn W,Lewine N,Gustavsen G,Pothier K,Brawer MK

    更新日期:2014-04-01 00:00:00

  • Clinical and economic outcomes by first-line treatment among women with HR+/HER2- metastatic breast cancer in a large US health plan database.

    abstract:BACKGROUND:Guidelines recommend that women with hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) metastatic breast cancer (mBC) initiate hormonal therapy before chemotherapy. This study compared outcomes of women with mBC who received chemotherapy first vs hormonal therapy. METHO...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1178108

    authors: Burton T,Byfield SD,Smith GL,Zanotti G,Bell TJ,Perkins JJ,Horblyuk R,Teitelbaum A

    更新日期:2016-08-01 00:00:00

  • Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.

    abstract::A randomized, double-blind study was carried out in 24 patients with stable angina pectoris to compare the efficacy of nadolol, a new beta-adrenoceptor antagonist, and propranolol. After a period on placebo, 14 patients received nadolol once daily and 10 patients propranolol 4-times daily over a 10-week dose-ranging p...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007997809111903

    authors: Furberg B,Dahlqvist A,Raak A,Wrege U

    更新日期:1978-01-01 00:00:00

  • Comparison of health utility weights among elderly patients receiving breast-conserving surgery plus hormonal therapy with or without radiotherapy.

    abstract:BACKGROUND:The selection of the most appropriate treatment combinations requires the balancing of benefits and harms of these treatment options as well as the patients' preferences for the resulting outcomes. OBJECTIVE:This research aimed at estimating and comparing the utility weights between elderly women with early...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2016.1257983

    authors: Ali AA,Xiao H,Tawk R,Campbell E,Semykina A,Montero AJ,Diaby V

    更新日期:2017-02-01 00:00:00

  • Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy.

    abstract:OBJECTIVE:To evaluate the efficacy and safety of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy (HRT) in a randomized, double-blind, placebo-controlled trial. METHODS:After a 6-week dietary lead-in period, 135 postmenopausal women who had been taking a stab...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079904X4167

    authors: Shepherd J,Packard C,Littlejohn TW 3rd,Walker J,Stein EA,Smith K,Kallend D,Blasetto JW

    更新日期:2004-10-01 00:00:00

  • Mapping MOS Sleep Scale scores to SF-6D utility index.

    abstract:OBJECTIVE:Deriving preference scores for the Medical Outcomes Study (MOS) Sleep Scale would enable its use in cost-utility analyses. The objective of this study was to map scores of the MOS Sleep Scale to a preference-based health-state utility index (SF-6D) scored from the SF-36 Health Survey (SF-36). RESEARCH DESIGN...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/030079907X210796

    authors: Yang M,Dubois D,Kosinski M,Sun X,Gajria K

    更新日期:2007-09-01 00:00:00

  • Quantitative characterization of the relationship between levels of extended corticosteroid use and related adverse events in a US population.

    abstract:OBJECTIVE:This retrospective study assessed the incidence and timing of adverse events (AEs) among patients prescribed varying dose levels of corticosteroids in the US. METHODS:Patients with selected autoimmune or inflammatory disease diagnoses between 2006 and 2015 were identified from a privately insured administrat...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2018.1474090

    authors: Rice JB,White AG,Johnson M,Wagh A,Qin Y,Bartels-Peculis L,Ciepielewska G,Nelson WW

    更新日期:2018-08-01 00:00:00

  • GOAL: multicenter, open-label, post-marketing study of flavocoxid, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin.

    abstract:OBJECTIVES:GOAL (Gauging Osteoarthritis [OA] with Limbrel*), an open-label, post-marketing study was performed to determine the overall efficacy and gastrointestinal (GI) tolerability of flavocoxid, a novel, plant-based, anti-inflammatory medication, in a 'real world' clinical practice setting. To this end, the study e...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究

    doi:10.1185/03007991003694522

    authors: Pillai L,Burnett BP,Levy RM,GOAL Study Cooperative Group.

    更新日期:2010-05-01 00:00:00

  • Results of the CAPPS: COPD--assessment of practice in primary care study.

    abstract:OBJECTIVE:Since many patients with COPD in the US are managed by primary care physicians, we evaluated adherence to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines in a primary care setting. METHODS:A cross-sectional study was conducted using a random sample of patients (n=50-150 per site)...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007995.2013.803957

    authors: Belletti D,Liu J,Zacker C,Wogen J

    更新日期:2013-08-01 00:00:00

  • Allergic rhinitis in patients with asthma: the Swiss LARA (Link Allergic Rhinitis in Asthma) survey.

    abstract:OBJECTIVE:To determine the characteristics of asthma (A) and allergic rhinitis (AR) among asthma patients in primary care practice. RESEARCH DESIGN AND METHODS:Primary care physicians, pulmonologists, and allergologists were asked to recruit consecutive asthma patients with or without allergic rhinitis from their dail...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/03007990902820733

    authors: Taegtmeyer AB,Steurer-Stey C,Spertini F,Bircher A,Helbling A,Miedinger D,Schafroth S,Scherer K,Leuppi JD

    更新日期:2009-05-01 00:00:00

  • Role of epidermal growth factor (EGF) in oesophageal mucosal integrity.

    abstract::Oesophageal mucosa has well established protective mechanisms, which operate within pre-epithelial, epithelial and post-epithelial compartments. Since refluxed acid and pepsin always act from the luminal side of the mucosa, protective factors like EGF, operating as a part of pre-epithelial defence, are thought to be p...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007999809113354

    authors: Marcinkiewicz M,Grabowska SZ,Czyzewska E

    更新日期:1998-01-01 00:00:00

  • The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.

    abstract:OBJECTIVE:To determine the ability of statins to prevent the development of new-onset type 2 diabetes mellitus through a meta-analysis of randomized, controlled trials. RESEARCH DESIGN AND METHODS:A systematic literature search through November 6, 2007 was conducted to identify randomized, placebo-controlled trials of...

    journal_title:Current medical research and opinion

    pub_type: 信件,评审

    doi:10.1185/030079908x292029

    authors: Coleman CI,Reinhart K,Kluger J,White CM

    更新日期:2008-05-01 00:00:00

  • Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.

    abstract::Doxofylline (7-(1,3-dioxalan-2-ylmethyl) theophylline) is a novel xanthine bronchodilator which differs from theophylline in that it contains a dioxalane group in position 7. Similarly to theophylline, its mechanism of action is related to the inhibition of phosphodiesterase activities, but in contrast it appears to h...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/030079901750120196

    authors: Dini FL,Cogo R

    更新日期:2001-01-01 00:00:00

  • A comparison of faecal blood loss caused by tenoxicam and piroxicam in normal healthy male volunteers.

    abstract::Faecal blood loss arising from tenoxicam at a dose of 20 mg/day was compared to that arising from piroxicam at a dose of 20 mg/day in a double-blind, parallel comparative study in 12 healthy male volunteers. Faecal blood loss was measured for a 1-week run-in on placebo, during 4 weeks of treatment and for a 2-week pos...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1185/03007998509109629

    authors: Bird HA,Hill J,Haw WM,Dixon JS,Harris PA,Wright V

    更新日期:1985-01-01 00:00:00

  • Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option.

    abstract:OBJECTIVE:To provide clinically relevant information on tadalafil 2.5 or 5 mg once daily for the treatment of erectile dysfunction (ED), by reviewing safety and efficacy study findings. Findings from an integrated analysis of trials of tadalafil 10 and 20 mg as needed are presented to provide context for the daily dosi...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802498440

    authors: Donatucci CF,Wong DG,Giuliano F,Glina S,Dowsett SA,Watts S,Sorsaburu S

    更新日期:2008-12-01 00:00:00

  • A current and comprehensive review of cyclin-dependent kinase inhibitors for the treatment of metastatic breast cancer.

    abstract:BACKGROUND:Resistance to endocrine treatment generally occurs over time, especially in the metastatic stage. In this paper, we aimed to review the mechanisms of cyclin-dependent kinase (CDK) 4/6 inhibition and clinical usage of new agents in the light of recent literature updates. SCOPE:A literature search was carried...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1080/03007995.2017.1348344

    authors: Bilgin B,Sendur MAN,Şener Dede D,Akıncı MB,Yalçın B

    更新日期:2017-09-01 00:00:00

  • Current approaches for prophylactic cranial irradiation in extrapulmonary small cell carcinoma.

    abstract:BACKGROUND:Small cell lung cancer (SCLC) patients, who have achieved complete or partial response after chemotherapy, should be followed with prophylactic cranial irradiation (PCI). PCI for extrapulmonary small cell carcinoma (EPSCC) is not routinely recommended. The purpose of this review is to discuss all aspects of ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2014.904771

    authors: Yazıcı O,Ozdemir NY,Sendur MA,Aksoy S,Zengin N

    更新日期:2014-07-01 00:00:00

  • Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.

    abstract:BACKGROUND:Most patients with hypertension require more than one drug to attain recommended blood pressure (BP) targets. Initiating therapy with two agents is recommended for patients at high risk of a cardiovascular event or with a BP > 20/10 mmHg above goal. Combination therapy is effective when comprised of agents w...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007990802597456

    authors: Ram CV

    更新日期:2009-01-01 00:00:00

  • Focus on quetiapine.

    abstract::Quetiapine fumarate is a novel dibenzothiazepine antipsychotic developed by Zeneca. It is marketed under the trade name 'Seroquel'. Quetiapine is well tolerated and clinically effective in the treatment of schizophrenia. The initial hope of investigators was that quetiapine would have antipsychotic potential and that ...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007999909114085

    authors: Green B

    更新日期:1999-01-01 00:00:00

  • Special considerations on the management of Latino patients with type 2 diabetes mellitus.

    abstract:BACKGROUND:Latinos are the largest minority population in the United States, and are characterized by higher rates of obesity and diabetes compared to Whites. The prevalence of diagnosed diabetes in Latinos is two-fold higher than in Caucasians, and Latinos suffer from higher rates of diabetic complications and mortali...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,评审

    doi:10.1185/03007995.2011.563505

    authors: Gonzalez AB,Salas D,Umpierrez GE

    更新日期:2011-05-01 00:00:00

  • Comparison of the effect of a hyaluronate-trehalose solution to hyaluronate alone on Ocular Surface Disease Index in patients with moderate to severe dry eye disease.

    abstract:OBJECTIVE:To describe a post hoc analysis comparing the effect of a hyaluronic acid (HA)-trehalose solution to an established eyedrop solution containing HA alone using Ocular Surface Disease Index (OSDI) score <19 as a threshold for moderate to severe dry eye disease (DED). METHODS:A phase III, randomized, controlled...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1080/03007995.2018.1434496

    authors: Doan S,Bremond-Gignac D,Chiambaretta F

    更新日期:2018-08-01 00:00:00

  • The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients: adaptation of INNOVATE to Sweden.

    abstract:BACKGROUND:Severe allergic asthma patients may not be controlled even with guideline recommended care, including inhaled corticosteroids, long-acting beta-2 agonists, theophylline, oral steroids and anti-leukotrienes. They experience exacerbations requiring intensive healthcare use and which may be fatal. Omalizumab, a...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079906X132389

    authors: Dewilde S,Turk F,Tambour M,Sandström T

    更新日期:2006-09-01 00:00:00

  • Evaluation of an isotonic tear in combination with topical cyclosporine for the treatment of ocular surface disease.

    abstract:PURPOSE:To determine whether a new category of artificial tear product, carboxymethylcellulose 0.5% with compatible solutes (CMC-solutes) (Optive, Allergan, Inc., Irvine, California) improves clinical outcomes when used adjunctively with topical cyclosporine 0.05% (Restasis, Allergan, Inc., Irvine, California) for the ...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章

    doi:10.1185/030079907X219670

    authors: Hardten DR,Brown MJ,Pham-Vang S

    更新日期:2007-09-01 00:00:00

  • Pharmaceutical industry-authored preprints: scientific and social media impact.

    abstract:AIM:Non-peer-reviewed manuscripts posted as preprints can be cited in peer-reviewed articles, which has both merits and demerits. International Committee of Medical Journal Editors guidelines mandate authors to declare preprints at the time of manuscript submission. We evaluated the trends in pharma-authored research p...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1080/03007995.2020.1853083

    authors: Subramanian K,Nalli A,Senthil V,Bhat A

    更新日期:2020-12-09 00:00:00

  • Chronic pain management--can we do better? An interview-based survey in primary care.

    abstract:BACKGROUND:Persisting pain is demoralising and debilitating for patients and their carers. Most patients with chronic pain do not need the services of a specialised pain clinic and are appropriately managed by their general practitioner (GP). METHOD:Interviewers approached 569 GPs to assess their satisfaction with the...

    journal_title:Current medical research and opinion

    pub_type: 杂志文章

    doi:10.1185/030079903125002478

    authors: Stannard C,Johnson M

    更新日期:2003-01-01 00:00:00

  • Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.

    abstract:BACKGROUND:Triptans are not identical and migraine sufferers respond differently to different triptans. Few studies have evaluated the efficacy of switching triptans in migraine patients who have shown poor response to another agent. OBJECTIVE:To investigate the efficacy and tolerability of almotriptan 12.5 mg in pati...

    journal_title:Current medical research and opinion

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1185/030079905X65448

    authors: Diener HC

    更新日期:2005-10-01 00:00:00